Autism biomarkers consortium for clinical trials

Project Type(s):

Principal Investigator(s):

RAB Lab website

This is a multicenter longitudinal study that aims to identify, develop and validate a set of measures that can be used as stratification biomarkers and/or sensitive and reliable objective measures of social impairment in ASD that could serve as markers of long term clinical outcome.


Project Period:
July 1, 2015 June 30, 2020

Funding Type(s):
Federal

Funder(s):
NIMH

Geographic Area(s):
Washington

Patient Population(s):
Children

Targeted Condition(s):
Autism Spectrum Disorder